Omega-3 polyunsaturated fatty acids for major depressive disorder
Expert Opinion on Investigational Drugs, 12/05/13
Effects of group music intervention on psychiatric symptoms and depression in patient with schizophrenia
Complementary Therapies in Medicine, 12/12/13
Chronic rhinitis and its association with headache frequency and disability in persons with migraine: Results of the American Migraine Prevalence and Prevention (AMPP) Study
Cephalalgia, 11/27/13
Vagus nerve stimulation for the treatment of epilepsy
Epilepsy Currents, 12/13/13
HIV-associated neurocognitive disorders - An issue of growing importance
Annals, Academy of Medicine, Singapore, 11/21/13
Overdiagnosis in low-dose computed tomography screening for lung cancer
JAMA Internal Medicine, 12/10/13
The effects of exercise training on anxiety
American Journal of Lifestyle Medicine, 11/27/13
A meta-analysis of inositol for depression and anxiety disorders
Human Psychopharmacology: Clinical and Experimental, 12/06/13
Influence of conventional cardiovascular risk factors and
lifestyle characteristics on cardiovascular disease after hematopoietic
cell transplantation
Journal of Clinical Oncology, 12/06/13
Statins and cognitive function: A systematic review
Annals of Internal Medicine, 11/21/13
Population impact of depression either as a risk factor or
consequence of type 2 diabetes in adults: A meta-analysis of
longitudinal studies
Asian Journal of Psychiatry, 12/11/13
Omega-3 fatty acid biomarkers and subsequent depressive symptoms
International Journal of Geriatric Psychiatry, 12/12/13
Acute and long-term treatment of late-life major depressive disorder: Duloxetine versus placebo
The American Journal of Geriatric Psychiatry, 12/10/13
©1999-2013 MDLinx, Inc.
No comments:
Post a Comment